Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Doximity, Inc. (“Doximity”) (NYSE: DOCS) common stock between June 24, 2021 and August 8, 2023, inclusive (the “Class Period”).
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the company’s business and operations. Specifically, Defendants repeatedly touted Doximity’s business prospects and the sustainability of the company’s revenue growth and profitability, while downplaying the impact of competition and tightening macroeconomic conditions on the company and its reliance on “upselling” products and services (such as additional advertising) to existing customers to sustain its performance and future growth.
Current Status of Case:
On December 29, 2025, the Lead Plaintiff filed a Motion for Preliminary Approval of the Class Action Settlement. There is a Preliminary Approval Hearing scheduled for March 4, 2026. This action is ongoing.
If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.